Peepul Capital-owned Medall Diagnostics plans to go for an IPO in 4 years

Medall's revenue, approximately Rs 400 crore at present, is estimated to increase to Rs 1,000 crore in three to four years

Medall Diagnostics, backed by private equity (PE) firm Peepul Capital, is planning to go for an initial public offering (IPO). The listing would help the company build its business organically, said a senior official. It may be noted that founder Raju venkataraman, who retired from the company last year, continues to remain on the board and hold a stake. Peepul Capital holds 80 per cent in the company.

Arjun Ananth, chief executive of integrated diagnostic services provider Medall Diagnostics, said: "We are planning to take the company public in four years. We are building a different kind of diagnostic company, with